Penumbra, Inc.

NYSE:PEN

Medical - Devices

Healthcare
$320.60 -0.72%

-$2.30 today

Market cap
$12.64B
Beta
0.70
P/E (TTM)
72.6
EPS (TTM)
$4.36
52W Low $221.26High $362.41

Volume 0.21M

Average 0.50M

PEN Pre-Tax Margin

Income before tax as a percentage of revenue.

Penumbra, Inc.NYSE: PEN

Pre-Tax Margin · Q2 FY2026 · quarter ended Jun 2026

Pre-tax margin narrows to 11.8%

Pre-tax margin was 11.8% in Q2 FY2026, down 1.5 pp from a year earlier. On a trailing-twelve-month basis it was 13.5%, up 0.0 pp year over year. Over 3 fiscal years it widened by 14.2 pp.

Context

  • Pre-tax margin widened in 2 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
11.8%+0.7 pp QoQ
Last fiscal yearDec 2025
14.6%+12.9 pp YoY
LTMJun 2026
13.5%+0.0 pp YoY
Pre-Tax Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-1.5 pp——
1 year+12.9 pp——
3 years+14.2 pp——
5 years——
10 years——

Pre-Tax Margin history

Percent of revenue · from the income statement

Latest · FY2025
14.6%
Year-over-year change
+12.9pp

Pre-Tax Margin vs competitors

How PEN compares with its peers on the latest reported figures

  • PEN's LTM Jun 2026 pre-tax margin of 13.5% is the 7th highest of the 9 companies compared; the peer median is 18.0%.
  • Its year-over-year change of +0.0 pp is the 6th highest of 9, against a peer median of +1.6 pp.
  • Over three fiscal years its change of +14.2 pp compares with a peer median of +2.1 pp.
PEN Competitors Peer median
Pre-Tax Margin for PEN and competitors
Company Period LTM level YoY 3-year change
LMATLeMaitre Vascular, Inc.LTM Mar 202631.5% +5.7 pp+13.1 pp
ISRGIntuitive Surgical, Inc.LTM Sep 202631.3% -1.7 pp+7.1 pp
EWEdwards Lifesciences CorporationLTM Jun 202621.8% -6.9 pp-11.9 pp
BSXBoston Scientific CorporationLTM Jun 202618.4% +2.2 pp+7.9 pp
MDTMedtronic plcLTM Jul 202617.6% +1.0 pp-0.3 pp
ABTAbbott LaboratoriesLTM Sep 202613.6% -5.0 pp+0.1 pp
PENPenumbra, Inc.LTM Jun 202613.5% +0.0 pp+14.2 pp
MMSIMerit Medical Systems, Inc.LTM Sep 202613.1% +2.8 pp+4.1 pp
ANGOAngioDynamics, Inc.LTM Feb 2026-10.0% +4.8 pp-2.2 pp
Peer median (excluding PEN) 18.0%+1.6 pp+2.1 pp

Competitors are the stored peer set for PEN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue747.59M847.13M1.06B1.19B1.4B
Cost of Revenue272.21M311.93M375.88M439.62M461.23M
Gross Profit475.38M535.21M682.64M755M942.44M
Gross Margin63.6%63.2%64.5%63.2%67.1%
Research & Development104.55M79.41M84.42M94.78M89.77M
Selling, General & Admin378.33M449.72M506.45M573.99M663.42M
Operating Expenses482.88M529.13M609.09M668.77M753.19M
Depreciation & Amortization16.41M24.32M27.26M23.7M17.47M
EBITDA7.84M29.96M108.65M45.99M223.91M
EBITDA Margin1.0%3.5%10.3%3.8%16.0%
Operating Income(7.5M)6.08M73.55M86.22M189.25M
Operating Margin-1.0%0.7%6.9%7.2%13.5%
Interest Income2.87M1.89M6.83M13.69M16.29M
Interest Expense1.93M1.75M1.74M1.42M1.31M
Other Income / Expenses(3M)(2.19M)6.1M(65.36M)15.88M
Income Before Tax(10.5M)3.89M79.65M20.87M205.13M
Pre-Tax Margin-1.4%0.5%7.5%1.7%14.6%
Income Tax Expense(13.13M)5.89M(11.3M)6.86M27.44M
Net Income5.28M(2M)90.95M14.01M177.69M
Net Margin0.7%-0.2%8.6%1.2%12.7%
EPS (Basic)0.14(0.05)2.370.364.57
EPS (Diluted)0.14(0.05)2.320.364.52
Weighted Avg Shares36.76M37.84M38.4M38.63M38.92M
Weighted Avg Shares (Diluted)37.88M37.84M39.22M39.27M39.29M

Penumbra, Inc.

NYSE:PEN

Intrinsic Alpha fair value

Locked

Current Price

$320.60

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.